Pharos iBio Co., Ltd. (KOSDAQ:388870)
6,020.00
-120.00 (-1.95%)
At close: Oct 2, 2026
| Market Cap | 77.93B +6.7% |
| Revenue (ttm) | n/a |
| Net Income | -9.49B |
| EPS | -733.12 |
| Shares Out | 12.95M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 45,837 |
| Open | 6,120.00 |
| Previous Close | 6,140.00 |
| Day's Range | 5,950.00 - 6,180.00 |
| 52-Week Range | 3,710.00 - 12,120.00 |
| Beta | -0.33 |
| Analysts | n/a |
| Price Target | n/a |
| Est. Earnings | Nov 11, 2026 |